9th Annual meeting of the International Cytokine and Interferon Society Meeting

国际细胞因子和干扰素学会第九届年会

• 批准号: 10389980
• 负责人: Katherine A. Fitzgerald
• 金额: $ 0.5万
• 依托单位: UNIV OF MASSACHUSETTS MED SCH WORCESTER
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-09-24 至 2022-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10389980
• 关键词: Amaze; Anti-Inflammatory Agents; Applications Grants; Area; Atherosclerosis; Autoimmune Diseases; Autoimmunity; Basic Science; Belief; Biology; Biomedical Research; Budgets; COVID-19; Cities; Clinical; Clinical Research; Collaborations; Communicable Diseases; Country; Custom; Cytokine Network Pathway; Development; Discipline; Disease; Event; Feedback; Female; Financial Support; Future; Government; Health; Human; Hybrids; Hypersensitivity; Immune; Immune System Diseases; Immune response; Immunity; Individual; Infection; Inflammation; Inflammatory; Institution; Interferons; International; Intuition; Investigation; Knowledge; Lightning; Love; Malignant Neoplasms; Mediating; Medicine; Metabolism; Molecular; Neurophysiology - biologic function; Parents; Participant; Persons; Pharmaceutical Preparations; Pharmacologic Substance; Physiological Processes; Play; Published Comment; Research; Research Personnel; Rheumatoid Arthritis; Role; Scientist; Societies; Students; Time; Travel; United States National Institutes of Health; Update; Videoconferencing; Wales; Work; career development; chemokine; cytokine; exhibitions; experience; flexibility; immune activation; insight; live stream; male; meetings; multidisciplinary; neurodevelopment; novel; novel therapeutic intervention; novel therapeutics; online community; symposium; virtual; virtual platform

NIH Support for Scientific Conference – R13 Grant Application ABSTRACT The purpose of this application is to request financial support for the Cytokines 2021 Hybrid Meeting: 9th Annual Meeting of the International Cytokine & Interferon Society (ICIS), October 17-20, 2021 in Cardiff, Wales, UK with synchronous Virtual Meeting Platform including live streamed and on-demand access through November 10, 2021. This Annual Meeting helps bridge the gap between the scientists performing basic research on molecular and cellular mechanisms of immune cell activation and function with those working to develop this knowledge into novel therapies. Cytokines and interferons are potent effectors of an immune response and also are master regulators of many diverse physiologic processes. The focus of this meeting is to bring together scientists from diverse areas of biomedical research to discuss the latest breakthroughs and insights into how cytokines and interferons regulate immunity, inflammation, metabolism, and cancer. Greater understanding of mechanisms of disease and novel concepts for therapy have and will continue to emerge from multidisciplinary gatherings where advances can be presented and discussed by established and trainee scientists. It is our hope that attendees will gain a deeper understanding of how cytokines network together to maintain health and gain an appreciation for the many potential strategies for targeting the network to create better drugs. The meeting will provide an outstanding forum for investigators in basic science and clinical research to present their most recent findings on the role of cytokines (including interferons, chemokines, and various pro- inflammatory/anti-inflammatory factors) in infection, cancer, allergy and autoimmunity, as well as in various other inflammatory and immune diseases. The meeting will also provide an opportunity for updates on the development of novel therapeutic interventions in these fields and help spur international collaborations among the meeting participants. Online presentations will be intertwined with physical presentations and sessions including virtual interactions, live commentaries, online & video chat forums, webcast video presentations and opportunities for individual discussion. ICIS Meetings Committee and Council have decided that use of a customized Virtual Meeting Platform even after travel restrictions are relaxed, will make the Annual Meeting more inclusive and make the meetings more sustainable. It is the firm belief of the Co-Chairs and Local Organizing Committee (diversely composed of 5 scientists, 3 male and 2 female) that, by bringing together leaders, junior investigators, and trainees working in the area of Interferon and Cytokine research, this meeting will inspire important new avenues of investigation and will be of great benefit to the career development of promising young investigators and trainees in the cytokine biology field.

NIH 对科学会议的支持 – R13 拨款申请 抽象的 本申请的目的是为 Cytokines 2021 混合会议：第九届年度会议请求财政支持 国际细胞因子与干扰素协会 (ICIS) 会议将于 2021 年 10 月 17 日至 20 日在英国威尔士卡迪夫举行 同步虚拟会议平台，包括截至 11 月 10 日的直播和点播访问， 2021 年。本次年会有助于缩小从事分子基础研究的科学家之间的差距 以及免疫细胞激活和功能的细胞机制，以及那些致力于发展这些知识的人 细胞因子和干扰素是免疫反应的有效效应物，也是主要的治疗方法。 许多不同生理过程的调节者本次会议的重点是将来自不同领域的科学家聚集在一起。 生物医学研究的不同领域，讨论细胞因子和细胞因子如何发挥作用的最新突破和见解 干扰素调节免疫、炎症、新陈代谢和癌症的机制。 疾病和新的治疗概念已经并将继续从多学科聚会中出现，其中 知名科学家和实习科学家可以介绍和讨论进展。 我们希望与会者能够更深入地了解细胞因子如何通过网络来维持 健康并了解针对网络创造更好药物的许多潜在策略。 会议将为基础科学和临床研究的研究者提供一个出色的论坛 他们关于细胞因子（包括干扰素、趋化因子和各种促细胞因子）作用的最新发现 炎症/抗炎因子）在感染、癌症、过敏和自身免疫以及其他各种疾病中 会议还将提供有关炎症和免疫疾病最新进展的机会。 在这些领域开发新的治疗干预措施，并有助于促进国际合作 会议参加者。 在线演示将与实体演示和会议交织在一起，包括虚拟互动、 现场评论、在线和视频聊天论坛、网络广播视频演示以及个人机会 ICIS 会议委员会和理事会已决定使用定制的虚拟会议。 即使旅行限制放宽后，平台也将使年会更具包容性，并使 会议更具可持续性。 这是联合主席和当地组委会（由 5 名科学家、3 名男性组成）的坚定信念。 和 2 名女性），通过将在该领域工作的领导者、初级研究人员和受训人员聚集在一起 干扰素和细胞因子研究，这次会议将激发重要的新研究途径，并将 对细胞因子生物学领域有前途的年轻研究者和实习生的职业发展大有裨益 场地。